omni
aaps
How Big Pharma Uses Charity Programs to Cover for Drug Price Hikes
How Big Pharma Uses Charity Programs to Cover for Drug Price Hikes
In August 2015, Turing Pharmaceuticals and its then-chief executive, Martin Shkreli, purchased a drug called Daraprim and immediately raised its price more than 5,000 percent. Within days, Turing contacted Patient Services Inc., or PSI, a charity that ...
The State of the Biosimilars Industry
The State of the Biosimilars Industry
Biosimilars continue to gain momentum in the U.S. To date, two biosimilars have been approved in the U.S., with many more in production and going through clinical trials.
Too Many 'Me-Too' Cancer Drugs? FDA Official Asks
Too Many 'Me-Too' Cancer Drugs? FDA Official Asks
A new type of cancer drug that takes the brakes off the body's immune system has given drugmakers some remarkable wins against the deadly disease, but a top U.S. regulator says too many companies are focused on the same approach.
Why Pharma Companies Prefer Drugs Over Vaccines
Why Pharma Companies Prefer Drugs Over Vaccines
When it comes to addressing disease, many industry observers and public health advocates believe that pharmaceutical companies prefer to invest in drugs rather than vaccines, as preventives are perceived to be inherently less profitable. A Harvard-Dart...
Value Pricing For Drugs: Whose Value, What Price?
Value Pricing For Drugs: Whose Value, What Price?
It is hard to read a newspaper these days without coming across a story about the high and ever increasing cost of drugs. The Wall Street Journal named drug prices the top health story of 2015. Stories about drug prices fall into two general categories...